In vitro diagnostic substances, reagents, test kits and sets

Ended Awarded Feb 24, 2016 Last action Jan 27, 2023

Contract number: HHSN261201600011I
Awardee: Boston Medical Center Corporation UEI JZ8RQC4EMDZ5
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Task orders: 4 $22,634 obligated

Award facts

Opportunity: N02CO5441602 Solicitation number

Full and Open Competition Tissue Purchase Order Acquisitions for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) Award Notice · Posted Jul 30, 2015
Combined order value: $22,634 Current and potential, with all options
Last date to order 100% complete: Feb 23, 2021
IDV ceiling <1% used: $6,500,000.00
Award type: Multiple award
Who can order: Only the awarding agency
NAICS code: 325413 In-Vitro Diagnostic Substance Manufacturing
PSC: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside: No set-aside
Competition: Competed under SAP · 7 offers Simplified Acquisition
Pricing: Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task order	Ordering agency	Obligated	Awarded
Tissue source site (TSS) for NCI's clinical proteomic tumor analysis consortium (CPTAC); 23 cases for payments 1-3. (23… 75N91018F00003	National Cancer Institute (NIH)	$0	Sep 17, 2018
Boston medical center:1106016 [18-066657] 75N91018F00004	National Cancer Institute (NIH)	$0	Sep 17, 2018
Cptac task order boston university HHSN26100002	National Cancer Institute (NIH)	$15,590	Aug 23, 2016
Boston medical center:1106016 [16-021895] HHSN26100001	National Cancer Institute (NIH)	$7,044	Feb 24, 2016

Action	Obligated	Date
Supplemental Agreement for work within scope P00003	$0	Jan 27, 2023
Other Administrative Action 2 · Tissue source site (TSS) for NCI's clinical proteomics tumor analysis consortium (CPTAC)idiqperiod of performance 2/24/2016 - 2/23/2021 (UNCHANGED)	$0	Sep 9, 2017
Other Administrative Action 1	$0	Apr 12, 2017
Original award	$0	Feb 24, 2016

HHSN261201600011I was awarded to Boston Medical Center Corporation by National Cancer Institute (National Institutes of Health) on February 24, 2016.

Orders under HHSN261201600011I have obligated $22,634. HHSN261201600011I's own ceiling is $6,500,000.

4 orders have been placed under HHSN261201600011I, the latest on September 17, 2018.

HHSN261201600011I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Yes. HHSN261201600011I is part of Tissue Source Site for Tumor Analysis.

The extent of competition for HHSN261201600011I was competed under sap. The government received 7 offers.

On GovTribe

Try for free Login